Description

.Beta.-D-Ribo-Hexopyranose, 1,6-Anhydro-4-o-(1-Cyclohexen-1-Ylmethyl)-3-Deoxy-2-o-Ethyl- is a specialized, high-purity carbohydrate derivative with a complex, modified sugar backbone. This compound serves as a critical advanced synthetic intermediate for the development of novel pharmaceutical agents and fine chemicals. It is primarily required by R&D and process development teams in the pharmaceutical, biotechnology, and agrochemical sectors for constructing complex molecular architectures.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of nucleoside analogs, antiviral agents, and other bioactive molecules.
• Glycochemistry Research: Used in the study and development of modified sugars and carbohydrate-based therapeutics.
• Agrochemical Synthesis: Intermediate in the production of specialized, high-value crop protection agents.
• Chiral Pool Starting Material: Provides a source of chirality and specific stereochemistry for asymmetric synthesis in fine chemical manufacturing.
• Academic & Industrial R&D: Employed in medicinal chemistry programs for lead optimization and structure-activity relationship (SAR) studies.

Basic Information

Product Name	.Beta.-D-Ribo-Hexopyranose, 1,6-Anhydro-4-o-(1-Cyclohexen-1-Ylmethyl)-3-Deoxy-2-o-Ethyl-
CAS No.	123920-70-7
Molecular Formula	C15H24O5
Molecular Weight	284.35 g/mol
Synonyms	1,6-Anhydro-4-O-[(1-cyclohexen-1-yl)methyl]-3-deoxy-2-O-ethyl-β-D-ribo-hexopyranose; 4-O-(1-Cyclohexen-1-ylmethyl)-1,6-anhydro-3-deoxy-2-O-ethyl-β-D-ribo-hexopyranose; 3-Deoxy-2-O-ethyl-4-O-(1-cyclohexen-1-ylmethyl)-1,6-anhydro-β-D-ribo-hexopyranose; Modified D-Ribose Derivative; Cyclohexenylmethyl Ether of 1,6-Anhydro-3-deoxy-2-O-ethyl-β-D-ribo-hexopyranose
EINECS	Contact for details

Quality Control

Every batch of this advanced intermediate is produced under strict quality management protocols. We provide comprehensive Certificates of Analysis (COA) detailing purity, identity, and impurity profiles, ensuring traceability and consistency for your critical synthesis workflows. Our quality systems support compliance with cGMP standards where required for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound should be handled in accordance with good laboratory practices, and the container should be kept sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 97.0%
Purity (HPLC, Area %)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.